Trial NCT03285607

View at ClinicalTrials.gov 
Org. Study IDs: 201711073
Secondary IDs: MCS110ZUS02T

Last trial update was posted on 2018-08-16

MeSH Interventions

Cyclophosphamide Doxorubicin Paclitaxel

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer Cancer of Breast

Stopping Reasons

Drug provider decided not to move forward with the study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID